Please login to the form below
OPEN Health mobilised to support outcomes with gene and other advanced therapies
Harnessing the power of collaborations to bring real insights and improve outcomes
The imminent explosion of gene and other advanced therapies brings with it a lot of hope and expectation along with unprecedented challenges faced by bio-pharma - big and small.
The power of the rare disease community has to be harnessed to get these potentially life changing treatments into health systems and to patients in a timely and sustainable fashion.
These are rapidly evolving and exciting times where everyone is learning together and collaboration is key to ensure best practice and novel approaches see widespread adoption.
OPEN Health brought together our existing knowledge in the space to develop experience based thinking on the topics of creating insight and value for gene and other advanced therapies. In addition OPEN Health always values opinion leaders in a particular field and were therefore delighted to be able to interview Nicki Redfern from bluebird bio to hear about their progress and the evolving landscape.
Finally we focus on what we see as a key challenge that requires a new approach. This is how do you deliver effective and sustained outcomes monitoring following initiation of one of these innovative therapies. Read our thinking in this space here.
Get in touch
For more information contact Gavin Jones | Director of Rare Disease | OPEN Health
GavinJones@OpenHealthGroup.com
+44 (0) 7795 038952
Company Details
OPEN Health
Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom
Latest content on this profile
- OPEN Health unites patient engagement experts to transform the patient experience
- OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement, deepening the organization's existing commitment to building patient-first solutions.
OPEN Health
- The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
- The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
OPEN Health
- OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
- OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
OPEN Health
- Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
- Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
OPEN Health
- Embracing the Patient Voice Within Publications
- This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders.
OPEN Health
- Navigating the nocebo effect through patient engagement is the key to setting patients up for success
- If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.
OPEN Health
